{"id":"W2532432536","doi":"10.1177/1756283x16674660","title":"Everolimus in the management of metastatic neuroendocrine tumours","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Everolimus; Medicine; Pasireotide; Neuroendocrine tumors; PI3K/AKT/mTOR pathway; Temsirolimus; Oncology; Sirolimus; Internal medicine; Lanreotide; Targeted therapy; Cancer; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005624404,0.0002529069,0.0005151316,0.0004288255,0.0001330575,0.0003118764,0.0002470898,0.000432885,0.0009942874],"category_scores_gemma":[0.0007276987,0.00006149196,0.0003384668,0.0003405915,0.0002118704,0.0003182213,0.0002739739,0.001548889,0.0004948638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003537991,"about_ca_system_score_gemma":0.000315433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00050378,"about_ca_topic_score_gemma":0.00153091,"domain_scores_codex":[0.9997805,0.00008142625,0.00002482517,0.00002111739,0.00007263477,0.00001965428],"domain_scores_gemma":[0.9997537,0.00008399585,0.00005990988,0.000008143072,0.00003530594,0.00005897617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001109234,0.0001804194,0.001407436,0.002054197,0.0002215298,0.002180992,0.00008126451,0.00148042,0.006719307,0.002950294,0.02305595,0.9585589],"study_design_scores_gemma":[0.001338077,0.004767771,0.02281629,0.003712766,0.0003758447,0.02471184,0.000148015,0.002338907,0.006095985,0.006819272,0.926804,0.00007116998],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0178039,0.9623722,0.001234485,0.007678291,0.0009173841,0.00003285648,0.00006268069,0.00006215479,0.009836085],"genre_scores_gemma":[0.2295355,0.7505064,0.003038601,0.006319694,0.003976482,0.00006696577,0.000290198,0.00004076188,0.00622551],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0009942874,"threshold_uncertainty_score":0.003326237,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04827955660449404,"score_gpt":0.4019686366715154,"score_spread":0.3536890800670214,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}